APA (7th ed.) Citation

Samelis, G. F., Kalofonos, H., Adamou, A., Kosmides, P., Skarlos, D., Aravantinos, G., . . . Dimopoulos, A. M. (2005). The combination of estramustine, vinorelbine, and mitoxantrone in hormone-refractory prostate cancer: A Phase II feasibility study conducted by the Hellenic Cooperative Oncology Group. Urology, 66(2), 382. https://doi.org/10.1016/j.urology.2005.02.023

Chicago Style (17th ed.) Citation

Samelis, Georgios Fotios, et al. "The Combination of Estramustine, Vinorelbine, and Mitoxantrone in Hormone-refractory Prostate Cancer: A Phase II Feasibility Study Conducted by the Hellenic Cooperative Oncology Group." Urology 66, no. 2 (2005): 382. https://doi.org/10.1016/j.urology.2005.02.023.

MLA (9th ed.) Citation

Samelis, Georgios Fotios, et al. "The Combination of Estramustine, Vinorelbine, and Mitoxantrone in Hormone-refractory Prostate Cancer: A Phase II Feasibility Study Conducted by the Hellenic Cooperative Oncology Group." Urology, vol. 66, no. 2, 2005, p. 382, https://doi.org/10.1016/j.urology.2005.02.023.